Saffron

botanicalstigma extract

At a glance

Best for
adults with mild-to-moderate depression seeking a botanical adjunct
Typical dose
28–30 mg/day standardized extract, split into two doses
Time to effect
Weeks (4–8)
Main caution
Contraindicated in pregnancy (uterine stimulant/abortifacient at higher doses)
Evidence strength: Good for mild-to-moderate depression; limited for PMS, sexual function, AMD, and cognition

What is it

Saffron is the dried red stigma of the autumn-flowering crocus ( Crocus sativus ), historically the world's most expensive spice by weight due to its labour-intensive hand harvesting. Its characteristic colour, aroma, and bioactivity derive from three principal compound classes: crocins (water-soluble carotenoid glycosides responsible for the deep yellow-red colour), picrocrocin (a glycoside that contributes the bitter flavour), and safranal (a volatile aldehyde derived from picrocrocin and responsible for much of the aroma). Saffron has a long traditional use in Persian, Mediterranean, Ayurvedic, and Chinese medicine for mood, menstrual, and digestive conditions, and modern clinical trials have focused predominantly on standardised aqueous-ethanolic extracts at doses far below culinary toxicity thresholds.

Is it worth it for you?

Worth considering if…

  • You have mild-to-moderate depression and want an adjunct or alternative with a tolerable side-effect profile
  • You will use a standardized extract for 4–8 weeks
  • You buy from reputable makers to avoid adulteration

Probably skip if…

  • You have severe depression needing first-line treatment
  • You are pregnant
  • You take serotonergic antidepressants without clinician oversight

Evidence at a glance

GoalEvidenceEffectBest fitTime
mild-to-moderate depressionGoodModerateadults with mild-to-moderate depressionWeeks (4–8)
premenstrual syndromeLimitedModestwomen with mood and physical PMS symptomsWeeks (across cycles)
antidepressant-related sexual dysfunctionLimitedModestpeople with SSRI-induced sexual dysfunctionWeeks
age-related macular degenerationLimitedSmall visual-function changespeople with early or intermediate AMDMonths
mild cognitive impairment and Alzheimer's diseaseLimitedModestpeople with mild-to-moderate Alzheimer's or MCIMonths

Evidence for 5 uses

AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.

mild-to-moderate depression

Supplement benefit
Good

Multiple randomized trials and meta-analyses find standardized saffron extract reduces depression severity more than placebo and comparably to standard antidepressants in mild-to-moderate cases. Trials are mostly small and several originate from one region, so confidence is good but not definitive.

Effect size: Moderate
Time to effect: Weeks (4–8)
Best fit: adults with mild-to-moderate depression
Less likely: people with severe or treatment-resistant depression

Bottom line: A reasonably evidenced botanical option for mild-to-moderate depression.

Evidence is mixed

Many positive trials are small and concentrated in a few research groups, limiting generalizability.

premenstrual syndrome

Supplement benefit
Limited

Small randomized trials report saffron reduces PMS symptom scores versus placebo over two cycles. The evidence base is limited to a few small studies, so confidence is low.

Effect size: Modest
Time to effect: Weeks (across cycles)
Best fit: women with mood and physical PMS symptoms
Less likely: those with severe PMDD

Bottom line: May ease PMS symptoms, supported by a few small trials.

antidepressant-related sexual dysfunction

Supplement benefit
Limited

Small trials suggest saffron improves SSRI-associated sexual dysfunction and some measures of arousal and function in both men and women. Studies are few and small, keeping confidence low.

Effect size: Modest
Time to effect: Weeks
Best fit: people with SSRI-induced sexual dysfunction
Less likely: general sexual dysfunction unrelated to medication

Bottom line: Preliminary help for SSRI-related sexual dysfunction.

age-related macular degeneration

Supplement benefit
Limited

Small randomized trials report modest improvements in retinal function and visual acuity measures with saffron in early AMD. The trials are small and short, so this remains preliminary.

Effect size: Small visual-function changes
Time to effect: Months
Best fit: people with early or intermediate AMD
Less likely: advanced AMD

Bottom line: Early, small-trial signal for visual function in AMD.

mild cognitive impairment and Alzheimer's disease

Supplement benefit
Limited

Small trials suggest saffron may improve cognitive scores in mild-to-moderate Alzheimer's, with some studies reporting effects comparable to donepezil. Evidence is limited to small studies and does not establish disease modification.

Effect size: Modest
Time to effect: Months
Best fit: people with mild-to-moderate Alzheimer's or MCI
Less likely: advanced dementia

Bottom line: Preliminary cognitive benefit in mild Alzheimer's, not yet robust.

How to take it

Typical dose
28–30 mg/day standardized extract
Higher studied dose
100–200 mg/day whole saffron powder in some trials
Timing
No fixed time of day
With food
Either
Split dosing
Typically divided into two daily doses
How long to try
Trial 4–8 weeks; keep total intake well below 1 g/day

What to track

  • mood symptoms
  • PMS symptoms if relevant
  • GI upset, headache, or appetite changes

Safety

Common side effects

mild GI upset, headache, appetite changes

Serious risks

  • uterine stimulant and abortifacient effects at higher doses
  • serious toxicity above ~5 g/day

Who should avoid it

  • pregnant women
  • people on serotonergic antidepressants without supervision

Pregnancy & breastfeeding

Contraindicated in pregnancy due to uterine-stimulant and abortifacient effects.

Interactions

antidepressants (serotonergic)Moderate

additive serotonergic effects reported in case reports

antihypertensivesMinor

possible additive blood-pressure lowering

antiplatelet drugsMinor

theoretical additive effect on platelets

Choosing a product

Look for

  • standardized extract (e.g. crocin/safranal content)
  • reputable brand to avoid adulteration
  • species Crocus sativus stated

Be skeptical of

  • natural Prozac
  • cures depression
  • reverses Alzheimer's

References by claim

mild-to-moderate depression

  • Shafiee et al., 2025PubMed (2025) link
  • Tóth et al., 2019PubMed (2019) link

premenstrual syndrome

  • Agha-Hosseini et al., 2008PubMed (2008) link

antidepressant-related sexual dysfunction

  • Kashani et al., 2013PubMed (2013) link
  • Mohammadzadeh-Moghadam et al., 2015PubMed (2015) link

age-related macular degeneration

  • Broadhead et al., 2019PubMed (2019) link
  • Broadhead et al., 2024PMC (2024) link

mild cognitive impairment and Alzheimer's disease

  • Akhondzadeh et al., 2010PubMed (2010) link
  • Farokhnia et al., 2014PubMed (2014) link

Track Saffron with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.

Coming to App Store
Evidence-based·Last reviewed May 30, 2026·Evidence current as of May 30, 2026·How we grade evidence

Disclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you’re pregnant, breastfeeding, on medications, or managing a chronic condition.